Our results indicate that higher TACC3 expression is strongly related to poorer disease-free survival (P = 0.032) and that rectal cancer patients not expressing TACC3 tend to have better overall survival, though the difference is not significance (P = 0.072). The gene discussed is TACC3; the disease is rectal cancer.